Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patients
Author(s) -
AnneGeneviève Marcelin,
Maxime Grudé,
Charlotte Charpentier,
Pantxika Bellecave,
L Le Guen,
Coralie Pallier,
Stéphanie Raymond,
Audrey Mirand,
Laurence Bocket,
Djeneba Fofana,
Constance Delaugerre,
Thuy Nguyen,
Brigitte Montès,
Hélène Jeulin,
Thomas Mourez,
Samira FafiKremer,
Corinne Amiel,
Catherine Roussel,
Julia Dina,
MaryAnne Trabaud,
Hélène Le GuillouGuillemette,
Sophie Vallet,
Anne Signori-Schmück,
Anne Maillard,
Virginie Ferré,
Diane Descamps,
Vincent Cálvez,
Philippe Flandre
Publication year - 2019
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkz021
Subject(s) - dolutegravir , elvitegravir , raltegravir , integrase , integrase inhibitor , regimen , medicine , virology , drug resistance , viral load , human immunodeficiency virus (hiv) , biology , antiretroviral therapy , genetics
To describe integrase strand transfer inhibitor (INSTI) resistance profiles and factors associated with resistance in antiretroviral-naive and -experienced patients failing an INSTI-based regimen in clinical practice.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom